Open AccessA randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis
Author(s) -
Keitaro Yokoyama,
T. Akiba,
Masafumi Fukagawa,
Masaaki Nakayama,
K Sawada,
Yoshito Kumagai,
Glenn M. Chertow,
Hiroyuki HIRAKATA
Publication year - 2013
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gft483
Subject(s) - medicine , sevelamer , transferrin saturation , parathyroid hormone , hemodialysis , randomized controlled trial , phosphate binder , gastroenterology , urology , ferritin , hyperphosphatemia , calcium , serum ferritin
JTT-751 is a novel phosphate binder containing ferric citrate as the active ingredient.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom